The drug is estimated to have been administered to 12,000 to 13,000 patients in Japan. All 20 dead patients developed liver dysfunction, and 210 similar side effect reports have been made, including suspected cases.
The drug is estimated to have been administered to 12,000 to 13,000 patients in Japan. All 20 dead patients developed liver dysfunction, and 210 similar side effect reports have been made, including suspected cases.
Kissei Pharmaceutical Co., Ltd. announced that for its vasculitis treatment drug “Tavneos” (generic name: avacopan), 20 deaths have been reported in Japan among patients who took the medication. This figure includes cases where a causal relationship is unclear. On the 15th, the company called on healthcare professionals to refrain from administering the drug to new patients.
Quarantine authorities are confirming whether travelers arriving in Japan from South America who report health problems had contact with rodents, which transmit the virus, and recommending that they visit medical institutions when necessary, Chief Cabinet Secretary Minoru Kihara said on Monday 11th May.
The risk of hantavirus spreading in Japan through person-to-person transmission is low, even if infected passengers from a cruise ship linked to a recent outbreak enter the country, the health ministry said Wednesday. The ministry called on the public to remain calm, after three people died in a suspected hantavirus outbreak on the cruise ship in the Atlantic Ocean. A Japanese national is among passengers on the ship.
Japan’s Finance Ministry on Tuesday called for a road map to raising out-of-pocket medical payments by patients aged 70 or older to reduce the health insurance premium burden on the working generation. The road map to consolidating their payment rates eventually to a uniform 30 pct should be created, the ministry said at a meeting of a subcommittee of the Fiscal System Council, which advises the finance minister.
Japan’s health minister Kenichiro Ueno said Friday he will call for nationwide vaccination to prevent measles. According to the health chief, 299 measles cases were reported between Jan. 1 and April 12, already exceeding the total figure for 2025. Cluster infections were observed at schools and others.
Japanese Prime Minister Sanae Takaichi said Thursday that the government will release 50 million medical gloves from its stockpile to medical institutions starting next month. The move came after some medical institutions expressed concerns about supplies of medical products amid the Middle East crisis.
Novel Alzheimer’s therapies have been given to 19 pct of outpatients who applied for the medications, according to a recent survey at a Tokyo hospital. The lecanemab and donanemab therapies for early-stage Alzheimer’s patients are now clinically available under Japan’s national health insurance scheme, which curbs a sharp rise in out-of-pocket medical expenses. Despite the relatively low-cost availability, however, the drugs have eventually been administered to only 87 out of 456 applicants, the survey by a study group at the Tokyo Metropolitan Institute for Geriatrics and Gerontology showed.
Japanese health minister Kenichiro Ueno on Friday 3rd April urged the public to exercise caution as measles cases are increasing. The number of people infected with the disease in Japan this year had reached 152 as of March 22, the highest total for the same period since 2020.
Barrier Free Japan